Vaccinesurvey SIGNED
Monitor population immunity against vaccine preventable diseases
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0Vaccinesurvey project word cloud
Explore the words cloud of the Vaccinesurvey project. It provides you a very rough idea of what is the project "Vaccinesurvey" about.
Project "Vaccinesurvey" data sheet
The following table provides information about the project.
| Coordinator |
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Organization address contact info |
| Coordinator Country | United Kingdom [UK] |
| Project website | https://www.vaccinesurveyproject.eu/ |
| Total cost | 1˙053˙000 € |
| EC max contribution | 1˙053˙000 € (100%) |
| Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
| Code Call | H2020-MSCA-RISE-2014 |
| Funding Scheme | MSCA-RISE |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-01-01 to 2019-06-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE | UK (LONDON) | coordinator | 328˙500.00 |
| 2 | POLO D'INNOVAZIONE DI GENOMICA, GENETICA E BIOLOGIA SCARL | IT (SIENA) | participant | 297˙000.00 |
| 3 | GENIALIS D.O.O | SI (LJUBLJANA) | participant | 220˙500.00 |
| 4 | UNIVERSITA DEGLI STUDI DI PERUGIA | IT (PERUGIA) | participant | 117˙000.00 |
| 5 | UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA | IT (ROMA) | participant | 90˙000.00 |
| 6 | MICROTEST MATRICES LTD | UK (LONDON) | participant | 0.00 |
| 7 | MINISTERE DE LA SANTE | BF (7003 Ouagadougou 03) | partner | 0.00 |
Map
Project objective
In the recent years an unprecedented effort has been made to increase the rates of childhood immunization in resource poor countries. This has translated into an increased number of children receiving vaccines and a parallel decrease in the rate of illnesses from vaccine preventable diseases. However, in some regions it has proven difficult to achieve optimal levels of immunization mainly because of issues concerning communication, management and poor utilization of resources. Recent studies have questioned the validity of available vaccine coverage data and the way they are collected. Currently, both the progress of the vaccination programs and indirectly the level of protection in a population are inferred on the basis of administrative records. This largely unverified information is also utilized as performance indicator to allocate funds from government and donor agencies. Such self-certification practice does not incentivize the optimization of resources while it has been increasingly questioned in terms of its validity and integrity. We propose to develop and validate an innovative technical solution based on an assay system that integrates multiplex capability and analytical performance, to simultaneously quantify antibody levels against the major vaccine components, with both automation and wireless connectivity to produce spatial-temporal co-ordinates of individual determinations. The multiplex capability will facilitate the analysis of cross coverage monitoring while generating reactivity profiles against the different vaccine components to discriminate vaccinated versus infected individuals. Spatial temporal co-ordinates of assay results will be used to generate interactive data sets for modeling changes in the age-specific risk of infection and the risk of outbreaks. The proposed system represents a formidable tool of unprecedented power to monitor the progress of different vaccination programs and experimentally validate record-based coverage data. The consortium proposes to develop an additional implementation of the technology, a low-cost portable microarray solution for healthcare point of testing (i.e. private doctors or pediatrician clinics, small district hospitals, rapid control of real vaccination profile in emergency situations) that converts the protein microarray for the determination of antibody protection against vaccines antigens into a lateral flow protein microarray, which can be coupled with software application for Smart phones to read the results.
Deliverables
| Production of second Ethical Review report | Documents, reports | 2019-11-26 11:58:48 |
| Production of interim disseminating knowledge plan | Documents, reports | 2019-11-26 11:58:47 |
| Production of initial disseminating knowledge plans | Documents, reports | 2019-11-26 11:58:47 |
| Nomination of the executive committee and work package leaders | Documents, reports | 2019-11-26 11:58:46 |
| Production of first Ethical Review report | Documents, reports | 2019-11-26 11:58:47 |
| Assay slides are produced and passed quality control | Other | 2019-11-26 11:58:46 |
| Updating the VSO and the database | Other | 2019-11-26 11:58:49 |
| Presentation of the technology alpha/beta version to stakeholders | Documents, reports | 2019-11-26 11:58:49 |
| Engage stakeholders and community to collect opinion and feedback | Documents, reports | 2019-11-26 11:58:49 |
| Mapping of Burkina Faso health care decision-making process | Documents, reports | 2019-11-26 11:58:47 |
Take a look to the deliverables list in detail: detailed list of Vaccinesurvey deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VACCINESURVEY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "VACCINESURVEY" are provided by the European Opendata Portal: CORDIS opendata.